A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care (MInD)

October 13, 2026 updated by: Amritha Subray Bhat, University of Washington

A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care (MInD)

The purpose of this study is to assess the effectiveness of a parenting intervention+usual care compared to usual care on postpartum depression and other mental health and parenting outcomes, as well as the feasibility and acceptability of the parenting intervention.

Study Overview

Detailed Description

Eligible and consenting participants will be randomized in a single blind manner (research visitor will be blinded to condition) at a 1:1 ratio to either MInD (parenting intervention and usual integrated care) or usual integrated care in their second trimester of pregnancy. Research assessments will be administered during pregnancy and post-partum.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98195
        • Amritha Bhat

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • English speaking pregnant women between gestational age (GA) 13 - 24 weeks
  • ≥ 18 years,
  • EPDS score ≥10,
  • Ability to send and receive text messages (TM)

Exclusion Criteria:

  • Severe substance use disorder in the past 6 months (score of 4 or above on the Alcohol Use Disorders Test AUDIT-C or a score of 6 or more on the Drug Abuse Screening Test (DAST).
  • Active suicidal ideation as measured by follow up to a positive answer to question 10 on the EPDS.
  • Bipolar disorder (Composite International Diagnostic Interview score ≥7) or psychotic disorder (assessed by chart review);
  • Multiple gestation (assessed by self-report and medical record);
  • Ongoing active treatment with psychotropic medications by mental health specialist (but not a PCP or Obstetrician).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Maternal Infant Dyadic Care

Perinatal integrated care and Promoting First Relationships-Brief

A brief version of the evidence based Promoting First Relationships (PFR) parenting intervention in which a parent is supported in appropriate interpretation of infant cues and in developing skills to effectively parent an infant. Sessions consist of reflective content (observing and reflecting back to the mother on patterns of dyadic interaction) and informational handouts. Reflective content will be delivered in person, and text messaging protocol will deliver informational content at developmentally appropriate times. PFR-B sessions are delivered in primary care settings beginning in the third trimester and continuing postpartum.

Integrated Care (IC) is an integrated care model that is effective in the treatment of perinatal depression. CC provides team driven, population focused, measurement guided and evidence based care to improve access and outcomes, control costs, and increase patient satisfaction.

Active Comparator: Control

Perinatal integrated care only

Integrated Care (IC) is an integrated care model that is effective in the treatment of perinatal depression. CC provides team driven, population focused, measurement guided and evidence based care to improve access and outcomes, control costs, and increase patient satisfaction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Perinatal Depression on the PHQ-9
Time Frame: Baseline, 3 Months Postpartum, 6 Months Postpartum

The PHQ-9 is a nine -item self-report depression measure with higher scores indicating increased symptom severity, total score ranging from 0 to 27 and is validated for use in the perinatal period.

Baseline, 3 Months Postpartum, 6 Months Postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Parental Self-Efficacy on the Self-Efficacy in a Nurturing Role (SENR)
Time Frame: Baseline, 3 Months Postpartum, 6 Months Postpartum

The SENR contains 16 items rated on 7-point scales regarding mothers' perceptions of their competence on basic skills required in caring for an infant (e.g., "I feel confident in my role as a parent," "I can soothe my baby easily when he or she is crying or fussing") In the prenatal assessment questions address how women expect to do once their infant is born (e.g., "I look forward to becoming a parent with confidence in my role as a parent," "I expect to be able to soothe my baby easily when he or she is crying or fussing"). Scores on the SENR are obtained by summing individual items to yield a total efficacy score, with higher scores reflecting greater feelings of efficacy. Minimum score is 16 and maximum score is 112.

Baseline, 3 Months Postpartum, 6 Months Postpartum
Change From Postpartum Baseline in Dyadic Interaction
Time Frame: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum

The Nursing Child Assessment Teaching Scale (NCAST) is an observational measure of the quality of caregiver-child dyadic interaction during a brief teaching activity, assessing caregiver sensitivity, responsiveness, and behaviors that foster the child's social-emotional and cognitive development. The caregiver subscale consists of four caregiver subscales comprising 50 items. Each item is scored dichotomously (0 = behavior not observed; 1 = behavior observed), giving a total caregiver score range of 0-50. Higher scores indicate more favorable caregiver-child interaction, reflecting greater caregiver sensitivity. NCATS is scored by observing a 3 minute videotaped session of mother and child interactive behavior.

6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
Change From Baseline in Disability on the World Health Organization Disability Assessment Schedule 2.0 (WHODAS)
Time Frame: Baseline, 3 Months Postpartum, 6 Months Postpartum

WHODAS 2.0 is a 12 item assessment of overall functioning. The scores assigned to each of the items - "none" (0), "mild" (1) "moderate" (2), "severe" (3) and "extreme" (4) - are summed, total score ranging from 0 to 48.

Higher scores indicate higher disability, that is higher values indicate a worse outcome.

Baseline, 3 Months Postpartum, 6 Months Postpartum
Change From Postpartum Baseline in Maternal Functioning on the Barkin Index of Maternal Functioning (BIMF)
Time Frame: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum

The BIMF is a 20-item self-report measure for use in the first year postpartum and can assess overall functioning in the context of new motherhood. It measures the functional domains of social support, management, mother-child interaction, infant care, self-care, adjustment, and psychological well-being (of the mother). It is measured only postpartum. A total score is generated from summing the 20 items and ranges from 0 to 120. Higher scores indicate better maternal functioning, a better outcome.

6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Working Alliance Inventory - Short Revised (WAI-SR) Scores Over Time
Time Frame: Prenatal to 6 months PP

The WAI-SR is a measure of therapeutic alliance. It contains 12 items using a 5 point likert scale. Score range is 12 to 60, with higher scores indicating better therapeutic alliance, a better outcome.

Prenatal to 6 months PP

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amritha S Bhat, MD, MPH, University of Washington

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2022

Primary Completion (Actual)

April 7, 2025

Study Completion (Actual)

April 7, 2025

Study Registration Dates

First Submitted

July 22, 2021

First Submitted That Met QC Criteria

August 6, 2021

First Posted (Actual)

August 10, 2021

Study Record Updates

Last Update Posted (Actual)

November 4, 2026

Last Update Submitted That Met QC Criteria

October 13, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe